TrialThe international journal of neuropsychopharmacology2023

A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation.

Tung-Ping Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.